Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series
- PMID: 22872730
- PMCID: PMC4618559
- DOI: 10.1093/infdis/jis490
Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series
Abstract
Vaccine or vaccine-reassortant rotavirus strains were detected in fecal specimens from 5 of 106 (4.7%) immunocompetent children who required treatment for rotavirus gastroenteritis at a large pediatric hospital in Texas in 2009-2010. Four strains were related to pentavalent rotavirus vaccine, whereas one was related to monovalent rotavirus vaccine. The contribution of these strains to each patient's illness was unclear given that 2 patients had prominent respiratory symptoms and 2 were concurrently infected with another pathogen (group F adenovirus and norovirus). Continued monitoring is necessary to assess the role of vaccine strains and vaccine-reassortant strains in pediatric rotavirus infections.
References
-
- Ward RL, Bernstein DI, Staat MA. Rotaviruses. In: Cherry J, Kaplan SLDemmler-Harrison GJ, et al., editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 6th Vol. 2. Saunders Elsevier; Philadelphia, PA: 2009. pp. 2245–50.
-
- Estes MK, Kapikian AZ. Rotaviruses. In: Knipe DM, Howley PM, editors. Field’s virology. 5th Vol. 2. Lippincott, Williams and Wilkins; Philadelphia, PA: 2007. pp. 1918–38.
-
- Santos N, Hoshino Y. Global distribution of rotavirus serotypes/geno-types and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15:29–56. - PubMed
-
- 2011. Rotarix [ package insert]. Rixensart, Belgium: GlaxoSmithKline Bio-logicals.
-
- 2011. RotaTeq [ package insert]. Whitehouse Station, NJ: Merck Vaccines.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
